NEW YORK (GenomeWeb News) – Knome today announced the start of its early access program for knomeClinic, a software suite for the interpretation of human genomes for biological relevance.

The software is designed to help medical researchers and clinicians interpret the human genome, and those accepted into the early access program will receive installation priority, access to pilot programs, and pre-release prototypes, Knome said. They also will have the "ability to influence knomeClinic's feature set upon general release," the Cambridge, Mass.-based firm added.